Resolving US Hemp Dilemma Takes Detour As House Starts Farm Bill Re-Authorization Journey

Where a US hemp product firm stands on whether de-scheduling the botanical as a controlled substance in the 2018 farm bill left a loophole allowing chemically derived and potentially intoxicating cannabinoid strains to qualify could determine whether it agrees with the detour.

• Source: Shutterstock

The House Agriculture Committee’s recent discussion of a five-year farm bill re-authorization was, as a member said, “the first step in a long journey.”

Where a US hemp product firm stands on whether de-scheduling the botanical as a controlled substance in the 2018 farm bill left a loophole allowing chemically derived and potentially intoxicating cannabinoid

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cannabis/CBD

More from Ingredients & Safety